What are the factors associated with the duration of remission of intra-articular corticosteroid injection in juvenile idiopathic arthritis?

• Published in: Clinical rheumatology Vol. 41; no. 12; pp. 3791 - 3796
• Main Authors: Aydın, Fatma, Çakar, Nilgün, Kurt, Tuba, Çelikel Acar, Banu, Çelikel, Elif, Özçakar, Zeynep Birsin, Yalçınkaya, Fatoş
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.12.2022; Springer Nature B.V
• Subjects: Arthritis; Atrophy; Histocompatibility antigen HLA; Inflammation; Injection; Joint diseases; Medicine; Medicine & Public Health; Methotrexate; Nonsteroidal anti-inflammatory drugs; Original Article; Patients; Pediatrics; Pigmentation; Recovery of function; Remission; Remission (Medicine); Rheumatology; Side effects; Statistical analysis; Steroids; Synovitis; Remission; Intra-articular corticosteroid injection; Juvenile idiopathic arthritis

Introduction Intra-articular corticosteroid injection (IACI) is generally used in the management of juvenile idiopathic arthritis (JIA) to obtain rapid relief of active synovitis and functional recovery and to prevent the need for regular systemic therapy. The aim of this study was to investigate th...